IP Library Granted Patent US 6,921,669
Granted Patent B2
US 6,921,669 · App. 10/030,999 · Granted Jul 26, 2005

Linker system for activating surfaces for bioconjugation

Assignee: Micronas Holding GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,921,669
App. No.
10/030,999
Granted
Jul 26, 2005
Kind
B2
Abstract

The present invention relates to a linker system for activating surfaces for bioconjugation, and particularly to a linker system having a novel hydrophilic spacer group. The inventive linker system may be used for the construction of sensor chips or biochips for the detection of sample biomolecules.

Claims (98)

1. A surface carrying a linker system comprising a compound for activating surfaces for bioconjugation having the following general formula (I):

X-[(Y 1 ) i —Q—(Y 2 ) j ] k —Z  (I)

wherein:

X is a reactive group capable of covalently binding to a surface and is selected from the group consisting of a SiW 3 group with W being a hydrolyzable atom or group, a group capable of forming free radicals on exposure to light, an anthrathione group or a derivative thereof, an anthraquinone group or a derivative thereof, and a benzophenone group or a derivative thereof;

Z is a reactive group capable of covalently binding to a biomolecule, is capable of nucleophilic substitution reactions, nucleophilic addition reactions, Diels-Alder reactions or radical substitutions, and is selected from the group consisting of a diene group, a dienophilic group, an aldehyde group, a hydroxyl group, a carboxylic acid group, an active ester group, an amino group, a thiol group, an aziridine group, an isocyanate group, an isothiocyanate group, an azide group, and a reactive leaving group;

X is not Z;

Y 1 and Y 2 are, independently from each other, CR 1 R 2 ;

R 1 and R 2 are, independently from each other, H, C 1 -C 4 alkyl, C 1 -C 4 alkoxy or C 1 -C 4 acyloxy;

i, j, and k are, independently from each other, an integer in the range from 1 to 10;

the total number of C atoms in Y 1 and Y 2 , the C atoms of R 1 and R 2 not included, is in the range of 2 to 100;

Q is a hydrophilic atom or group selected from the group consisting of O, NH, C═O, O—C═O and CR 3 R 4 ;

R 3 and R 4 are, independently from each other, selected from the group consisting of H, OH, C 1 -C 4 alkoxy and C 1 -C 4 acyloxy; and

R 3 and R 4 are not H at the same time;

wherein when Q=NH, Z is not NH 2 ;

wherein when k>1, the Q's for each [(Y 1 ) i —Q—(Y 2 ) j ] k are independently selected from each other; and wherein the linker system is covalently bonded to a biomolecule

wherein said biomolecule is a partner of a specifically interacting system of complementary binding partners;

wherein said specifically interacting system of complementary binding partners is based on nucleic acid/complementary nucleic acid, peptide nucleic acid/nucleic acid, enzyme/substrate, receptor/effector, lectin/sugar, antibody/antigen, avidin/biotin or strept-avidin/biotin interaction; and

wherein said antibody is a polyclonal, monoclonal, chimeric or single-chain antibody or a functional fragment or derivative of such antibodies.

2. Surface according to claim 1 , wherein said surface is selected from the group consisting of a SiO 2 surface of a silicon wafer, glass, quartz, fused silica, gold and a polymer.

3. Medical or diagnostic instrument comprising a surface according to claim 1 .

4. Process for the detection of a biomolecule which is a partner of a specifically interacting system of complementary binding partners, comprising the steps of:

a) contacting a surface with a sample suspected to contain the complementary binding partner,

b) removing non-specifically bound sample components in a washing step, and

c) detecting specifically bound sample components;

wherein the surface carries a linker s stem comprising a compound for activating surfaces for bioconjugation having the following general formula (I):

X—[(Y 1 ) i —Q—(Y 2 ) j ] k —Z  (I)

wherein:

X is a reactive group capable of covalently binding to a surface and is selected from the group consisting of a SiW 3 group with W being a hydrolyzable atom or group, a group capable of forming free radicals on exposure to light, an anthrathione group or a derivative thereof, an anthraquinone group or a derivative thereof, and a benzophenone group or a derivative thereof;

Z is a reactive group capable of covalently binding to the biomolecule, is capable of nucleophilic substitution reactions, nucleophilic addition reactions, Diels-Alder reactions or radical substitutions, and is selected from the group consisting of a diene group, a dienophilic group, an aldehyde group, a hydroxyl group, a carboxylic acid group, an active ester group, an amino group, a thiol group, an aziridine group, an isocyanate group, an isothiocyanate group, an azide group, and a reactive leaving group;

X is not Z;

Y 1 and Y 2 are, independently from each other, H, C 1 R 2 ;

R 1 and R 2 are, independently from each other, H, C 1 -C 4 alkyl, C 1 -C 4 alkoxy or C 1 -C 4 acyloxy;

i, j, and k are, independently from each other, an integer in the range from 1 to 10;

the total number of C atoms in Y 1 and Y 2 the C atoms of R 1 and R 2 not included, is in the range of 2 to 100;

Q is a hydrophilic atom or group selected from the group consisting of O, NH, C═O—C═O and CR 3 R 4 ;

R 3 and R 4 are, independently from each other, selected from the group consisting of H, OH, C 1 -C 4 alkoxy and C 1 -C 4 acyloxy; and

R 3 and R 4 are not H at the same time;

wherein when Q=NH, Z is not NH 2 ;

wherein when k>1, the Q's for each [(Y 1 ) i —Q—(Y 2 ) j ] k are independently selected from each other; and

wherein the linker system is covalently bonded to the biomolecule and said biomolecule is a partner of a specifically interacting system of complementary binding partners.

5. Process according to claim 4 wherein for said detecting, a colored, fluorescent, bioluminescent, chemoluminescent, phosphorescent or radioactive label; an enzyme; an antibody or a functional fragment or derivative thereof, a protein A/gold based system; a biotin/avidin/streptavidin based system; or an enzyme electrode based system is used.

6. The method of claim 4 , wherein said surface comprises a silicon oxide or gold.

7. Process for the isolation of a biomolecule which is a partner of a specifically interacting system of complementary binding partners, comprising the steps of:

a) contacting a surface with a sample suspected to contain the biomolecule complementary binding partner,

b) removing non-specifically bound sample components in a washing step, and, optionally,

c) eluting specifically bound sample components;

wherein the surface carries a linker system comprising a compound for activating surfaces for bioconjugation having the following general formula (I):

X—[(Y 1 ) i —Q—(Y 2 ) j ] k —Z  (I)

wherein:

X is a reactive group capable of covalently binding to a surface and is selected from the group consisting of a SiW 3 group with W being a hydrolyzable atom or group, a group capable of forming free radicals on exposure to light, an anthrathione group or a derivative thereof, an anthraquinone group or a derivative thereof, and a benzophenone group or a derivative thereof;

Z is a reactive group capable of covalently binding to the biomolecule, is capable of nucleophilic substitution reactions, nucleophilic addition reactions, Diels-Alder reactions or radical substitutions, and is selected from the group consisting of a diene group, a dienophilic group, an aldehyde group, a hydroxyl group, a carboxylic acid group, an active ester group, an amino group, a thiol group, an aziridine group, an isocyanate group, an isothiocyanate group, an azide group, and a reactive leaving group;

X is not Z;

Y 1 and Y 2 are, independently from each other, CR 1 R 2 ;

R 1 and R 2 are, independently from each other, H, C 1 -C 4 alkyl, C 1 -C 4 alkoxy or C 1 -C 4 acyloxy;

i, j, and k are, independently from each other, an integer in the range from 1 to 10;

the total number of C atoms in Y 1 and Y 2 , the C atoms of R 1 and R 2 not included, is in the range of 2 to 100;

Q is a hydrophilic atom or group selected from the group consisting of O, NH, C═O, O—C═O and CR 3 R 4 ;

R 3 and R 4 are, independently from each other, selected from the group consisting of H, OH, C 1 -C 4 alkoxy and C 1 -C 4 acyloxy; and

R 3 and R 4 are not H at the same time;

wherein when Q=NH, Z is not NH 2 ;

wherein when k>1, the Q's for each [(Y 1 ) i —Q—(Y 2 ) j ] k are independently selected from each other; and

wherein the linker system is covalently bonded to the biomolecule and the biomolecule is a partner of a specifically interacting system of complementary binding partners.

8. A method of affinity chromatography comprising the steps of:

providing a surface as an affinity matrix; and performing affinity chromatography with the affinity matrix;

wherein the surface carries a linker system comprising a compound for activating surfaces for bioconjugation having the following general formula (I):

X—[(Y 1 ) i —Q—(Y 2 ) j ] k —Z  (I)

wherein:

X is a reactive group capable of covalently binding to a surface and is selected from the group consisting of a SiW 3 group with W being a hydrolyzable atom or group, a group capable of forming free radicals on exposure to light, an anthrathione group or a derivative thereof, an anthraquinone group or a derivative thereof, and a benzophenone group or a derivative thereof;

Z is a reactive group capable of covalently binding to a biomolecule is capable of nucleophilic substitution reactions, nucleophilic addition reactions, Diels-Alder reactions or radical substitutions, and is selected from the group consisting of a diene group, a dienophilic group, an aldehyde group, a hydroxyl group, a carboxylic acid group, an active ester group, an amino group, a thiol group, an aziridine group, an isocyanate group, an isothiocyanate group, an azide group, and a reactive leaving group;

X is not Z;

Y 1 and Y 2 are, independently from each other, CR 1 R 2 ;

R 1 and R 2 are, independently from each other, H, C 1 -C 4 alkyl, C 1 -C 4 alkoxy or C 1 -C 4 acyloxy;

i, j, and k are, independently from each other, an integer in the range from 1 to 10;

the total number of C atoms in Y 1 and Y 2 , the C atoms of R 1 and R 2 not included, is in the range of 2 to 100;

Q is a hydrophilic atom or group selected from the group consisting of O, NH, C═O, O—C═O and CR 3 R 4 ;

R 3 and R 4 are, independently from each other, selected from the group consisting of H, OH, C 1 -C 4 alkoxy and C 1 -C 4 acyloxy; and

R 3 and R 4 are not H at the same time;

wherein when Q=NH, Z is not NH 2 ;

wherein when k>1, the Q's for each [(Y 1 ) i —Q—(Y 2 ) j ] k are independently selected from each other; and

wherein the linker system is covalently bonded to a biomolecule and the biomolecule is a partner of a specifically interacting system of complementary binding partners.

9. A method of detecting a biomolecule comprising the steps of:

providing a sensor chip or biochip comprising a surface; and detecting a biomolecule with the sensor chip or biochip;

wherein the surface carries a linker system comprising a compound for activating surfaces for bioconjugation having the following general formula (I):

X—[(Y 1 ) i —Q—(Y 2 ) i ] k —Z  (I)

wherein:

X is a reactive group capable of covalently biding to a surface and is selected from the group consisting of a SiW 3 group with W being a hydrolyzable atom or group, a group capable of forming free radicals on exposure to light, an anthrathione group or a derivative thereof, an anthraquinone group or a derivative thereof, and a benzophenone group or a derivative thereof;

Z is a reactive group capable of covalently binding to a biomolecule, is capable of nucleophilic substitution reactions, nucleophilic addition reactions, Diels-Alder reactions or radical substitutions, and is selected from the group consisting of a diene group, a dienophilic group, an aldehyde group, a hydroxyl group, a carboxylic acid group, an active ester group, an amino group, a thiol group, an aziridine group, an isocyanate group, an isothiocyanate group, an azide group, and a reactive leaving group;

X is not Z;

Y 1 and Y 2 are, independently from each other, CR 1 R 2 ;

R 1 and R 2 are, independently from each other, H, C 1 -C 4 alkyl, C 1 -C 4 alkoxy or C 1 -C 4 acyloxy;

i, j, and k are, independently from each other, an integer in the range from 1 to 10;

the total number of C atoms in Y 1 and Y 2 , the C atoms of R 1 and R 2 not included, is in the range of 2 to 100;

Q is a hydrophilic atom or group selected from the group consisting of O, NH, C═O, O—C═O and CR 3 R 4 ;

R 3 and R 4 are, independently from each other, selected from the group consisting of H, OH, C 1 -C 4 alkoxy and C 1 -C 4 acyloxy; and

R 3 and R 4 are not H at the same time;

wherein when Q=NH, Z is not NH 2 ;

wherein when k>1, the Q's for each [(Y 1 ) i —Q—(Y 2 ) j ] k are independently selected from each other; and

wherein the linker system is covalently bonded to a biomolecule and the biomolecule is a partner of a specifically interacting system of complementary binding partners.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2024
From: IP SUCCESSOR FUND 21 L.P.
To: SAFEGUARD BIOSYSTEMS HOLDINGS LIMITED
Reel/Frame 069084/0644 →
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2024
From: MLC50 LP INC.
To: SAFEGUARD BIOSYSTEMS HOLDINGS LIMITED
Reel/Frame 069084/0649 →
SECURITY INTEREST Recorded Aug 16, 2024
From: SAFEGUARD BIOSYSTEMS HOLDINGS LIMITED
To: MLC50 LP INC.
Reel/Frame 068317/0453 →
SECURITY INTEREST Recorded Feb 25, 2021
From: SAFEGUARD BIOSYSTEMS HOLDINGS LIMITED
To: IP SUCCESSOR FUND 21 L.P.
Reel/Frame 055411/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2017
From: TDK-MICRONAS GMBH
To: KLAPPROTH, HOLGER
Reel/Frame 044197/0993 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2017
From: KLAPPROTH, HOLGER
To: SAFEGUARD BIOSYSTEMS HOLDINGS LTD.
Reel/Frame 044198/0129 →
CHANGE OF NAME Recorded Nov 22, 2017
From: MICRONAS GMBH
To: TDK-MICRONAS GMBH
Reel/Frame 044496/0645 →
CHANGE OF NAME Recorded Nov 22, 2017
From: MICRONAS HOLDING GMBH
To: MICRONAS GMBH
Reel/Frame 044802/0836 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2004
From: BIOCHIP TECHNOLOGIES GMBH
To: HOLGER KLAPPROTH
Reel/Frame 015042/0072 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2004
From: KLAPPROTH, HOLGER
To: MICRONAS HOLDING GMBH
Reel/Frame 015042/0080 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2002
From: KLAPPROTH, HOLGER
To: BIOCHIP TECHNOLOGIES GMBH
Reel/Frame 012686/0950 →
Priority Claims (1)
EP 00110428 · May 16, 2000 · regional
Continuity (1)
Related Publication 20030022189A1 · Jan 30, 2003